Framework: Horizon 2020. PHC-26-2014, Grant Agreement 643552.
Funding: 4.034.222 €
m-RESIST (Mobile Therapeutic Attention for Pacients with Treatment Resistant Schizophrenia) is a European project that developed a therapeutic procedure supported by mobile devices. Involving actively patients with resistant Schizophrenia treatment and their caregivers. Both patients and caregivers could manage the pathology themselves. m-RESIST implemented an analytic model in order to advance in the understanding of the resistant scizophrenia and predict behavioural issues of the illness. The m-RESIST solution has been tested in 3 pilots with real users carried out between Catalonia, Israel and Hungary.
It established a reaction alarm system, protocols and recommendations to support the professional in the clinical decisions.
Subscriu-te i rep cada mes novetats i notícies al teu email